The Scientist

» rare diseases and developmental biology

Most Recent

image: A Gut Feeling

A Gut Feeling

By | April 1, 2016

See profilee Hans Clevers discuss his work with stem cells and cancer in the small intestine.

0 Comments

image: Guts and Glory

Guts and Glory

By | April 1, 2016

An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.

1 Comment

image: Adjustable Brain Cells

Adjustable Brain Cells

By | February 18, 2016

Neighboring neurons can manipulate astrocytes. 

1 Comment

image: $280 Million Boost for Disease Genomics

$280 Million Boost for Disease Genomics

By | January 18, 2016

The genomics arm of the National Institutes of Health has pledged a total of $280 million for research into the genetic bases of disease.

0 Comments

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

image: The Cyclopes of Idaho, 1950s

The Cyclopes of Idaho, 1950s

By | December 1, 2015

A rash of deformed lambs eventually led to the creation of a cancer-fighting agent.

0 Comments

image: Blood Cell Development Reimagined

Blood Cell Development Reimagined

By | November 9, 2015

A new study is rewriting 50 years of biological dogma by suggesting that mature blood cells develop much more rapidly from stem cells than previously thought.

0 Comments

image: Shire Buys Rare Disease Drug Developer

Shire Buys Rare Disease Drug Developer

By | November 2, 2015

The Irish drugmaker is set to acquire the Massachusetts-based Dyax in a $5.9 billion deal.

0 Comments

image: Adding Padding

Adding Padding

By | November 1, 2015

Adipogenesis in mice has alternating genetic requirements throughout the animals’ lives.

0 Comments

image: Stem Cell Therapy In Utero

Stem Cell Therapy In Utero

By | October 13, 2015

An upcoming clinical trial aims to correct for a disease of fragile bones in affected babies before they are born.

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Grass Routes
    Features Grass Routes

    Researchers are discovering a suite of new locations and functions of endocannabinoid receptors that play roles in sickness and in health.

  3. Studies Retracted After UCLA Investigation
  4. Trump Nominates Sam Clovis to Lead USDA Research
AAAS